Maschmeyer G - Search Results

1

Update on management of infections in cancer and stem cell transplant patients.

Neuburger S, Maschmeyer G. Neuburger S, et al. Among authors: maschmeyer g. Ann Hematol. 2006 Jun;85(6):345-56. doi: 10.1007/s00277-005-0048-2. Epub 2006 Mar 11. Ann Hematol. 2006. PMID: 16532331 Review.

2

Interventional antimicrobial therapy in febrile neutropenic patients. Study Group of the Paul Ehrlich Society for Chemotherapy.

Link H, Maschmeyer G, Meyer P, Hiddemann W, Stille W, Helmerking M, Adam D. Link H, et al. Among authors: maschmeyer g. Ann Hematol. 1994 Nov;69(5):231-43. doi: 10.1007/BF01700277. Ann Hematol. 1994. PMID: 7948312 Clinical Trial.

3

[Empirical antimicrobial therapy in neutropenic patients].

Maschmeyer G. Maschmeyer G. Ther Umsch. 1996 Nov;53(11):854-62. Ther Umsch. 1996. PMID: 8984691 Review. German.

4

Management of infections during intensive treatment of hematologic malignancies.

Maschmeyer G, Hiddemann W, Link H, Cornely OA, Buchheidt D, Glass B, Adam D. Maschmeyer G, et al. Ann Hematol. 1997 Jul-Aug;75(1-2):9-16. doi: 10.1007/s002770050306. Ann Hematol. 1997. PMID: 9322678 Review.

5

Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.

Behre G, Link H, Maschmeyer G, Meyer P, Paaz U, Wilhelm M, Hiddemann W. Behre G, et al. Among authors: maschmeyer g. Ann Hematol. 1998 Feb;76(2):73-80. doi: 10.1007/s002770050366. Ann Hematol. 1998. PMID: 9540761 Clinical Trial.

6

Granulocyte colony-stimulating factor shortens duration of critical neutropenia and prolongs disease-free survival after sequential high-dose cytosine arabinoside and mitoxantrone (S-HAM) salvage therapy for refractory and relapsed acute myeloid leukemia. German AML Cooperative Group.

Kern W, Aul C, Maschmeyer G, Kuse R, Kerkhoff A, Grote-Metke A, Eimermacher H, Kubica U, Wörmann B, Büchner T, Hiddemann W. Kern W, et al. Among authors: maschmeyer g. Ann Hematol. 1998 Sep;77(3):115-22. doi: 10.1007/s002770050425. Ann Hematol. 1998. PMID: 9797080 Clinical Trial.

7

Interventional antimicrobial therapy in febrile neutropenic patients.

Maschmeyer G. Maschmeyer G. Diagn Microbiol Infect Dis. 1999 Jul;34(3):205-12. doi: 10.1016/s0732-8893(99)00024-3. Diagn Microbiol Infect Dis. 1999. PMID: 10403100 Review.

8

Changing patterns of infections and antimicrobial susceptibilities.

Maschmeyer G, Noskin GA, Ribaud P, Sepkowitz KA. Maschmeyer G, et al. Oncology (Williston Park). 2000 Aug;14(8 Suppl 6):9-16. Oncology (Williston Park). 2000. PMID: 10989819 Free article. Review.

9

Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s.

Maschmeyer G, Braveny I. Maschmeyer G, et al. Eur J Clin Microbiol Infect Dis. 2000 Dec;19(12):915-25. doi: 10.1007/s100960000410. Eur J Clin Microbiol Infect Dis. 2000. PMID: 11205628 Review.

10

Four patients with AL amyloidosis treated with high-dose chemotherapy and autologous stem cell transplantation.

Reich G, Held T, Siegert W, Kampf D, Dörken B, Maschmeyer G. Reich G, et al. Among authors: maschmeyer g. Bone Marrow Transplant. 2001 Feb;27(3):341-3. doi: 10.1038/sj.bmt.1702766. Bone Marrow Transplant. 2001. PMID: 11277185

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters